Ally Bridge Group Expands Early-stage Cancer Solution Portfolio with Investment in Quantum Surgical

4 June 2018

Ally Bridge Group ("ABG"), a leading cross-border life science investment group, has completed a Series A investment, as the first part of a total of $50 million raise, in Quantum Surgica